You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cemiplimab

Showing 1 - 25 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Trial (Cemiplimab)

Available
    • Cemiplimab
    • (no location specified)
    Nov 9, 2023

    Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

    Recruiting
    • Metastatic Uveal Melanoma
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 2, 2023

    Colon Cancer Trial in Houston (Cemiplimab)

    Not yet recruiting
    • Colon Cancer
    • Cemiplimab
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2023

    Advanced NSCLC Trial (fianlimab, cemiplimab, Placebo)

    Not yet recruiting
    • Advanced Non-Small Cell Lung Cancer
    • (no location specified)
    Mar 27, 2023

    NSCLC Trial (fianlimab, cemiplimab, Pemetrexed)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    Mar 23, 2023

    Advanced NSCLC Trial (BNT116, Cemiplimab)

    Not yet recruiting
    • Advanced Non-Small Cell Lung Cancer
    • (no location specified)
    Jan 3, 2023

    Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Advanced Cancer
    • Cemiplimab
    • +3 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 19, 2023

    Hormone Receptor-positive Breast Cancer Trial in Tampa (Cemiplimab, Capecitabine)

    Recruiting
    • Hormone Receptor-positive Breast Cancer
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 30, 2022

    Melanoma Trial in Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

    Recruiting
    • Melanoma
    • Knoxville, Tennessee
      University of Tennessee Medical Center
    Dec 20, 2022

    Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)

    Active, not recruiting
    • Glioblastoma
    • Recurrent Glioblastoma
    • Boston, Massachusetts
    • +3 more
    Jan 13, 2023

    Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

    Not yet recruiting
    • Advanced Dedifferentiated Liposarcoma
    • +5 more
    • (no location specified)
    Jan 11, 2023

    NSCLC Trial in Pittsburgh (M1774, Cemiplimab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Pittsburgh, Pennsylvania
      UPMC Cancer Center
    May 22, 2023

    Lung Cancer Trial in Houston (Cemiplimab, Kevzara (Sarilumab))

    Not yet recruiting
    • Lung Cancer
    • Cemiplimab
    • Kevzara (Sarilumab)
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Squamous Cell Carcinoma, Oropharynx Cancer, Head Neck Cancer Trial in Houston (SAR444245, Cemiplimab)

    Not yet recruiting
    • Squamous Cell Carcinoma
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 7, 2022

    Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

    Recruiting
    • Solid Tumor, Adult
    • +19 more
    • SNS-101 (anti-VISTA)
    • Cemiplimab
    • Irving, Texas
    • +2 more
    May 24, 2023

    Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in New York (Cemiplimab, Cisplatin, Docetaxel)

    Recruiting
    • Locally Advanced Head and Neck Squamous Cell Carcinoma
    • Cemiplimab
    • +2 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Sep 6, 2022

    Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +13 more
    • (no location specified)
    Aug 29, 2023

    Melanoma Trial in Orlando, Knoxville (Fianlimab, Cemiplimab, Pembrolizumab)

    Recruiting
    • Melanoma
    • Orlando, Florida
    • +1 more
    Jul 5, 2022

    Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)

    Not yet recruiting
    • Advanced Solid Tumor
    • Metastatic Solid Tumor
    • (no location specified)
    Aug 5, 2022

    NSCLC Trial in Buderim, Adelaide (6-Thio-2'-Deoxyguanosine, Cemiplimab)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Buderim, Queensland, Australia
    • +1 more
    Jul 5, 2022

    Cemiplimab to Historical Standard of Care in France

    Recruiting
    • Cancer/Squamous Cell Carcinoma of Skin
    • Cemiplimab
    • France, France
      (unnamed)
    Jun 6, 2022

    Advanced Solid Tumors Trial in United States (REGN7075, cemiplimab)

    Recruiting
    • Advanced Solid Tumors
    • San Francisco, California
    • +9 more
    Jan 30, 2023

    NSCLC Trial (Cemiplimab)

    Recruiting
    • Non-small Cell Lung Cancer
    • Cemiplimab
    • Konstanz, Baden-Württemberg, Germany
    • +8 more
    Jan 6, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in United States (REGN4336, Cemiplimab, 18F-DCFPyL)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Palo Alto, California
    • +8 more
    Jan 17, 2023

    Secondary Angiosarcoma, Locally Advanced Sarcoma, Metastasis Trial in Nijmegen (Cemiplimab)

    Recruiting
    • Secondary Angiosarcoma
    • +2 more
    • Cemiplimab
    • Nijmegen, Netherlands
      RadboudUMC
    Jan 19, 2022